Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The syndrome of apparent mineralocorticoid excess (AME) is an inherited form of human hypertension thought to result from a deficiency of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD). This enzyme normally converts cortisol to inactive cortisone and is postulated to thus confer specificity for aldosterone upon the mineralocorticoid receptor. We have analysed the gene encoding the kidney isozyme of 11 beta HSD and found mutations on both alleles in nine of 11 AME patients (eight of nine kindreds). These mutations markedly affect enzymatic activity. They thus permit cortisol to occupy the renal mineralocorticoid receptor and thereby cause sodium retention and hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [588]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Molecular basis of human hypertension: Role of angiotensinogen
Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850
Fetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Ulick, S., Milora, R. V., Findling, J. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90250-x · Cited by 1,259
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Research works printed but not linked: 3
- Werder, E., Zachmann, M., Völlmin, J.A., Veyrat, R. & Prader, A. Unusual steroid excretion in a child with low renin hypertension. Res. Steroids 6, 385–389 (1974).
- Winter, J.S.D. & McKenzie, J.K. (1977). A syndrome of low-renin hypertension in children. In Juvenile Hypertension (eds New, M.I. & Levin, L.S.) 123–133 (Raven Press, New York, 1977).
- Higuchi, R. Recombinant PCR. In PCR Protocols (eds Innis, M.A., Gelfand, D.H., Sninsky, J.J. & White, T.J.) 177–183 (Academic, San Diego,1990).
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
“…of the nephron thatries a gene duplication that fuses regulatory sequences of the 11- express ENaC, shows homozygous loss-of-functionhydroxylase gene to coding sequences conferring aldosterone synthase enzymatic activity on the encoded gene product. mutations in AME patients (Mune et al., 1995).”
Essential Hypertension: Part I: Definition and Etiology
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,087
Simon, D. B., Karet, F. E., Hamdan, J. M., Pietro, A. D., Sanjad, S. A., & Lifton, R. P. (1996) · Nature Genetics · doi:10.1038/ng0696-183 · Cited by 907
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Seckl, J. R., & Holmes, M. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0515 · Cited by 754
Hansson, J. H., Nelson-Williams, C., Suzuki, H., Schild, L., Shimkets, R., Lu, Y., Canessa, C., Iwasaki, T., Rossier, B., & Lifton, R. P. (1995) · Nature Genetics · doi:10.1038/ng0995-76 · Cited by 754
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases
Meneton, P., Jeunemaitre, X., de Wardener, H. E., & Macgregor, G. A. (2005) · Physiological Reviews · doi:10.1152/physrev.00056.2003 · Cited by 703
Molecular Genetics of Human Blood Pressure Variation
Lifton, R. P. (1996) · Science · doi:10.1126/science.272.5262.676 · Cited by 629
Levy, D., DeStefano, A. L., Larson, M. G., O’Donnell, C. J., Lifton, R. P., Gavras, H., Cupples, L. A., & Myers, R. H. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.477 · Cited by 595
Inoue, I., Nakajima, T., Williams, C. S., Quackenbush, J., Puryear, R., Powers, M., Cheng, T., Ludwig, E. H., Sharma, A. M., Hata, A., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119343 · Cited by 547
Endothelial Nitric Oxide Synthase Gene Is Positively Associated With Essential Hypertension
Miyamoto, Y., Saito, Y., Kajiyama, N., Yoshimura, M., Shimasaki, Y., Nakayama, M., Kamitani, S., Harada, M., Ishikawa, M., Kuwahara, K., et al. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.3 · Cited by 519
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Self-citationGenetics of Human Cardiovascular Disease
Kathiresan, S., & Srivastava, D. (2012) · Cell · doi:10.1016/j.cell.2012.03.001 · Cited by 496
Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association
Elijovich, F., Weinberger, M. H., Anderson, C. A. M., Appel, L. J., Bursztyn, M., Cook, N. R., Dart, R. A., Newton-Cheh, C. H., Sacks, F. M., & Laffer, C. L. (2016) · Hypertension · doi:10.1161/hyp.0000000000000047 · Cited by 482
Molecular Endocrinology of Hydroxysteroid Dehydrogenases*
Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0302 · Cited by 438
Prenatal programming of adult hypertension in the rat
Vehaskari, V. M., Aviles, D. H., & Manning, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00484.x · Cited by 398
11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
GLUCOCORTICOID AND MINERALOCORTICOID RECEPTORS: Biology and Clinical Relevance
Funder, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.231 · Cited by 320
Lindsay, R. S., Lindsay, R. M., Edwards, C. R. W., & Seckl, J. R. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1200 · Cited by 310
Seckl, J. R. (1997) · Steroids · doi:10.1016/s0039-128x(96)00165-1 · Cited by 298
Elements of a Paracrine Tubular Renin-Angiotensin System Along the Entire Nephron
Rohrwasser, A., Morgan, T., Dillon, H. F., Zhao, L., Callaway, C. W., Hillas, E., Zhang, S., Cheng, T., Inagami, T., Ward, K., et al. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1265 · Cited by 292
The genetic dissection of essential hypertension
Cowley, A. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1967 · Cited by 290
Hypertension and the cortisol-cortisone shuttle
Quinkler, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030138 · Cited by 286
Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
Kotelevtsev, Y., Brown, R. W., Fleming, S., Kenyon, C., Edwards, C. R. W., Seckl, J. R., & Mullins, J. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4445 · Cited by 284
Lindsay, R. S., Lindsay, R. M., Waddell, B. J., & Seckl, J. R. (1996) · Diabetologia · doi:10.1007/s001250050573 · Cited by 283
Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms
Lang, F., & Cohen, P. (2001) · Science's STKE · doi:10.1126/stke.2001.108.re17 · Cited by 274
Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure
Qin, W., Rudolph, A. E., Bond, B. R., Rocha, R., Blomme, E. A. G., Goellner, J. J., Funder, J. W., & McMahon, E. G. (2003) · Circulation Research · doi:10.1161/01.res.0000080521.15238.e5 · Cited by 262
11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239
“Inhibition of this enzyme with liquorice (Stewart et al., 1987) or disruption of the 11 -HSD2 gene in mice (Kotelevtsev et al., 1999) or humans (Mune et al., 1995; Dave-Sharma et al., 1998) leads to the syndrome of apparent mineralocorticoid excess (AME).”
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Diaz, R., Brown, R. W., & Seckl, J. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02570.1998 · Cited by 224
Physiologic Programming of the Fetus
Seckl, J. R. (1998) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30091-5 · Cited by 214
Genes for blood pressure: an opportunity to understand hypertension
Ehret, G. B., & Caulfield, M. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs455 · Cited by 209
Harris, H. J., Kotelevtsev, Y., Mullins, J. J., Seckl, J. R., & Holmes, M. C. (2001) · Endocrinology · doi:10.1210/endo.142.1.7887 · Cited by 209
Kaserer, T., Beck, K., Akram, M., Odermatt, A., & Schuster, D. (2015) · Molecules · doi:10.3390/molecules201219880 · Cited by 207
Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1
Ricketts, M. L., Verhaeg, J. M., Bujalska, I., Howie, A. J., Rainey, W. E., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4706 · Cited by 197
Odermatt, A., Arnold, P., Stauffer, A., Frey, B. M., & Frey, F. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28762 · Cited by 190
Hypertension: genes and environment
Hamet, P., Pausová, Z., Adarichev, V. A., Adaricheva, K., & Tremblay, J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816040-00001 · Cited by 190
11β-hydroxysteroid dehydrogenases: changing glucocorticoid action
Seckl, J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.001 · Cited by 185
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.017 · Cited by 181
Genetic determinants of human hypertension.
Lifton, R. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8545 · Cited by 181
Julier, C., Delepine, M., Keavney, B., Terwilliger, J., Davis, S., Weeks, D. E., Bui, T., Jeunemaitre, X., Velho, G., Froguel, P., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2077 · Cited by 178
Dave-Sharma, S., Wilson, R. C., Harbison, M. D., Newfield, R., Azar, M. R., Krozowski, Z. S., Funder, J. W., Shackleton, C. H. L., Bradlow, H. L., Wei, J.-Q., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4986 · Cited by 177
A panoramic view of gene expression in the human kidney
Chabardès-Garonne, D., Méjean, A., Aude, J.-C., Cheval, L., Di Stefano, A., Gaillard, M.-C., Imbert-Teboul, M., Wittner, M., Balian, C., Anthouard, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234604100 · Cited by 176
11β-Hydroxysteroid dehydrogenases: Key enzymes in determining tissue-specific glucocorticoid effects
Edwards, C. R. W., Benediktsson, R., Lindsay, R. S., & Seckl, J. R. (1996) · Steroids · doi:10.1016/0039-128x(96)00033-5 · Cited by 169
Funder, J. W., & Myles, K. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940344 · Cited by 169
Molecular Genetics of Human Hypertension: Role of Angiotensinogen
Corvol, P. L., & Jeunemaître, X. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.5.0312 · Cited by 166
Molecular genetics of human hypertension
Luft, F. C. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00004 · Cited by 165
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess
New, M. I., & Wilson, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12790 · Cited by 164
Chantong, B., Kratschmar, D. V., Nashev, L. G., Balázs, Z., & Odermatt, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-260 · Cited by 163
Molecular Basis of Human Salt Sensitivity: The Role of the 11 -Hydroxysteroid Dehydrogenase Type 2
Lovati, E., Ferrari, P., Dick, B., Jostarndt, K., Frey, B. M., Frey, F. J., Schorr, U., & Sharma, A. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6098 · Cited by 163
Mineralocorticoid hypertension
Stewart, P. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06102-9 · Cited by 162
The type I and type II 11β-hydroxysteroid dehydrogenase enzymes
Krozowski, Z. S., Li, K. X. Z., Koyama, K., Smith, R. E., Obeyesekere, V. R., Stein, A., Sasano, H., Coulter, C., Cole, T. J., & Sheppard, K. E. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00074-6 · Cited by 157
Speirs, H., Seckl, J. R., & Brown, R. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810105 · Cited by 155
Seckl, J. R., & Walker, B. R. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.007 · Cited by 154
Aldehyde Dehydrogenase 2 Gene Is a Risk Factor for Myocardial Infarction in Japanese Men.
Takagi, S., Iwai, N., Yamauchi, R., Kojima, S., Yasuno, S., Baba, T., Terashima, M., Tsutsumi, Y., Suzuki, S., Morii, I., et al. (2002) · Hypertension Research · doi:10.1291/hypres.25.677 · Cited by 152
Corvol, P. L., Persu, A., Gimenez‐Roqueplo, A., & Jeunemaître, X. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1324 · Cited by 151
Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action
Penning, T. M. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg022 · Cited by 149
Association of the Gsα Gene With Essential Hypertension and Response to β-Blockade
Jia, H., Hingorani, A. D., Sharma, P., Hopper, R., Dickerson, C., Trutwein, D., Lloyd, D. D., & Mj, B. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.8 · Cited by 147
Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues.
Smith, R. E., Maguire, J. A., Stein-Oakley, A. N., Sasano, H., Takahashi, K., Fukushima, K., & Krozowski, Z. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784076 · Cited by 146
Cortisol metabolism in hypertension
Hammer, F., & Stewart, P. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.001 · Cited by 143
A genetic defect resulting in mild low-renin hypertension
Wilson, R. C., Dave-Sharma, S., Wei, J., Obeyesekere, V. R., Li, K. D., Ferrari, P., Krozowski, Z. S., Shackleton, C. H. L., Bradlow, L., Wiens, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10200 · Cited by 143
Holness, M. J., LANGDOWN, M. L., & Sugden, M. C. (2000) · Biochemical Journal · doi:10.1042/bj3490657 · Cited by 140
Genetic variations related to hypertension: a review
Tanira, M. O. M., & Al-Balushi, K. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001780 · Cited by 137
In Vivo 11β-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice
Ferrari, P., Sansonnens, A., Dick, B., & Frey, F. J. (2001) · Hypertension · doi:10.1161/hy1101.096112 · Cited by 136
Gamba, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00311.2004 · Cited by 134
Glucocorticoid metabolism and reproduction: a tale of two enzymes
Michael, A. E., Thurston, L. M., & Rae, M. (2003) · Reproduction · doi:10.1530/rep.0.1260425 · Cited by 128
Primary aldosteronism: an update on screening, diagnosis and treatment
Rossi, G. P., Pessina, A. C., & Heagerty, A. M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f4b3e6 · Cited by 127
Wyrwoll, C. S., & Holmes, M. C. (2011) · Neuroendocrinology · doi:10.1159/000331345 · Cited by 126
Davani, B., Khan, A., Hult, M., Mårtensson, E., Okret, S., Efendić, S., Jörnvall, H., & Oppermann, U. C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000600200 · Cited by 126
Takami, S., Katsuya, T., Rakugi, H., Sato, N., Nakata, Y., Kamitani, A., Miki, T., Higaki, J., & Ogihara, T. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00457-3 · Cited by 126
Bujalska, I. J., Shimojo, M., Howie, A., & Stewart, P. M. (1997) · Steroids · doi:10.1016/s0039-128x(96)00163-8 · Cited by 125
A review of the genetics of essential hypertension
Binder, A. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3280d357f9 · Cited by 125
Sato, A., & Funder, J. W. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828470 · Cited by 125
11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
Wake, D. J., & Walker, B. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.015 · Cited by 124
Ambrosius, W. T., Bloem, L. J., Zhou, L., Rebhun, J. F., Snyder, P. M., Wagner, M. A., Guo, C., & Pratt, J. H. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.631 · Cited by 123
How safe is long-term prenatal glucocorticoid treatment?
Seckl, J. R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540370067039 · Cited by 118
Jamieson, A., Wallace, E. M., Andrew, R., Nunez, B. S., Walker, B. R., Fraser, R., White, P. C., & Connell, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6031 · Cited by 117
Self-citationDominiczak, A. F., Negrin, D. C., Clark, J. S., Brosnan, M. J., McBride, M., & Alexander, M. Y. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.164 · Cited by 117
Glucocorticoids and laminitis in the horse
Johnson, P. J., Slight, S. H., Ganjam, V. K., & Kreeger, J. M. (2002) · Veterinary Clinics of North America Equine Practice · doi:10.1016/s0749-0739(02)00015-9 · Cited by 116
Morineau, G., Boudi, A., Barka, A., Gourmelen, M., Dégeilh, F., Hardy, N., Al-Halnak, A., Soliman, H. R., Gosling, J. P., Julien, R., et al. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1397 · Cited by 116
Maser, E., & Oppermann, U. C. T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00365.x · Cited by 116
Liddle Syndrome: Genetics and Mechanisms of Na+ Channel Defects
Warnock, D. G. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200112000-00002 · Cited by 115
Zirconium oxide: analysis of MG63 osteoblast-like cell response by means of a microarray technology
Carinci, F., Pezzetti, F., Volinia, S., Francioso, F., Arcelli, D., Farina, E., & Piattelli, A. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00486-1 · Cited by 112
Apparent Mineralocorticoid Excess: Report of Six New Cases and Extensive Personal Experience
Morineau, G., Sulmont, V., Salomon, R., Fiquet‐Kempf, B., Jeunemaître, X., Nicod, J., & Ferrari, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060570 · Cited by 111
Sarkar, S., Tsai, S., Nguyen, T. T., Plevyak, M. P., Padbury, J. F., & Rubin, L. P. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.6.r1966 · Cited by 110
Molecular Basis for Hypertension in the “Type II Variant” of Apparent Mineralocorticoid Excess
Li, A., Tedde, R., Krozowski, Z., Pala, A., Li, K. X. Z., Shackleton, C. H. L., Mantero, F., Palermo, M., & Stewart, P. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301955 · Cited by 110
Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation
Ferrari, P., & Krozowski, Z. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00978.x · Cited by 106
Activating Mutation of the Renal Epithelial Chloride Channel ClC-Kb Predisposing to Hypertension
Jeck, N., Waldegger, S., Lampert, A., Boehmer, C., Waldegger, P., Lang, P. A., Wissinger, B., Friedrich, B., Risler, T., Moehle, R., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000129824.12959.f0 · Cited by 106
Genomewide Linkage Scan of Resting Blood Pressure: HERITAGE Family Study
Rice, T., Rankinen, T., Chagnon, Y. C., Province, M. A., Përusse, L., Leon, A. S., Skinner, J. S., Wilmore, J. H., Bouchard, C., & Rao, D. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000018911.46067.6e · Cited by 105
Molecular genetics of essential hypertension
Singh, M., Singh, A., Pandey, P., Chandra, S., Singh, K. A., & Gambhir, I. S. (2016) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1116543 · Cited by 104
Impact of Prenatal Stress on Neuroendocrine Programming
Viltart, O., & Vanbesien-Mailliot, C. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.204 · Cited by 99
General overview of mineralocorticoid hormone action
Agarwal, M. K., & Mirshahi, M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00038-8 · Cited by 99
Central Hypertensive Effects of Aldosterone
Gómez-Sánchez, E. P. (1997) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1997.0157 · Cited by 99
Insights into glucocorticoid-associated hypertension
Brem, A. S. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.20637 · Cited by 98
Metadata
- Authors
- Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature Genetics
- Published
- 1995-08-01
- Volume
- 10
- Issue
- 4
- Pages
- 394-399
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2034652601
- Semantic Scholar
- 39186032ea056bd01960beb7624e326d14d1cda1
- Cited by
- 619
- References
- 57
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 10 · 2022: 4 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 13 · 2013: 15 · 2012: 15
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk034400-10, 5r01dk042169-12)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42169, DK-34400)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- apparent mineralocorticoid excess, hypertension, 11β-hydroxysteroid dehydrogenase, genetic mutations, mineralocorticoid receptor, cortisol, aldosterone, sodium retention, genetic hypertension, kindred
- MeSH terms
- Adolescent, Adult, Base Sequence, Child, Child, Preschool, Female, Humans, Hydroxysteroid Dehydrogenases, Hypertension, Infant, Infant, Low Birth Weight, Infant, Newborn, Isoenzymes, Kidney, Male, Mineralocorticoids, Molecular Sequence Data, Mutation, Risk Factors, DNA Primers, 11-beta-Hydroxysteroid Dehydrogenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.